The agency awarded more than $562 million from the coronavirus rescue package to a dozen U.S. companies to support domestic manufacturing of supplies such as pipette tips, protective packaging, swabs and reagents used in COVID-19 testing.
“Supporting manufacturing of needed products like these will help strengthen the supply chain for COVID-19 tests, including rapid at-home tests, with the goal of increasing supply and availability of tests that are high quality and easy to use,” HHS said in a news release.
Some of the investments include:
- $192.5 million awarded to Nalge Nunc International Corp., a subsidiary of Thermo Fisher Scientific, to increase domestic manufacturing of pipette tips.
- $6.5 million awarded to US Cotton to increase domestic production capacity for polyester-tipped swabs used in COVID-19 home test kits and mass testing sites.
- $14.7 million awarded to Steripack to boost domestic production of collection vials used for nasal swab tests.
Read the full HHS news release here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
